C ardiovascular research has struggled to advance the field of regenerative medicine, due in part to the lack of a unique and unequivocal marker for resident adult cardiac stem cells capable of mediating repair. In fact, the concept of myocardial regeneration that was initially advanced over a decade ago used the stem cell marker c-Kit to identify presumptive cardiac stem cells. 1, 2 During the ensuing years, the c-Kit+ cardiac stem cell population has become the focus of intense and diverse investigation by hundreds of laboratories worldwide at both the basic and clinical levels. [3] [4] [5] [6] [7] [8] [9] [10] At present, the presence and participation of c-Kit+ cells in myocardial development and response to pathological stress or injury are indisputable. 2, 4, 8, [10] [11] [12] However, controversy persists on the roles(s) that cells expressing c-Kit play in cardiac biology. Such divergent perspectives suggest that fundamental understanding has not been achieved and that additional study is warranted to provide sorely needed novel insight(s). The present study was conceived and initiated to examine myocardial c-Kit biology with fresh perspective using a unique approach yielding novel findings.
Phenotypically, c-Kit serves as a marker of multiple cell types including stem cells, most often associated with hematopoietic progenitor cells, but in fact is present from early embryogenesis and persists in wide distribution throughout various adult tissues. 13, 14 Functionally, c-Kit protein is a kinase that, upon activation by its cognate ligand stem cell factor (SCF), serves to induce cell proliferation, survival, and transcriptional activation.
14 Variation in temporal appearance and expression level of c-Kit in multiple cell types and in response to environmental stimuli is indicative of a dynamically regulated protein that does not necessarily respect traditional nomenclature of a stem cell marker. Despite years of study, details of c-Kit signaling cascades and downstream targets remain obscure, 15 and the respective activities for surface-expressed versus internal c-Kit remain poorly characterized. 16 In the cardiac context, c-Kit expression has been documented in multiple cell types including (but not necessarily limited to) myocytes, endothelial cells, cardiac progenitor cells (CPCs), and mesenchymal stem cells. 17, 18 Indeed, observations of c-Kit protein induction suggest that stress responses and myocyte remodeling serve as inductive stimuli for expression of this stem cell marker in cardiomyocytes. 4, 19 Given the heterogeneous expression pattern for c-Kit that is not restricted solely to a canonical cardiac stem cell, the complex and varied findings derived from study of various genetically engineered c-Kit lineage-tracing models might indeed even be an expected outcome. 18 Furthermore, every experimental approach to define c-Kit+ cell fate possesses inherent strengths and weaknesses to be considered when deriving conclusions. Although the advantages of a genetically engineered knock-in model are well known, 20 the inevitable silencing of one c-Kit allele perturbs endogenous c-Kit biology with potentially significant consequences for stem cell function. Furthermore, imperfect tagging efficiency in 
Novelty and Significance
What Is Known?
• The mammalian heart has a limited capacity for self-renewal and repair. The identity of cells responsible for this regenerative activity remains an area of active investigation.
• c-Kit is a receptor tyrosine kinase used to identify cardiac stem and progenitor cell populations. c-Kit signaling promotes cell proliferation and survival.
• The cardiac c-Kit cell population is heterogeneous; it contributes to myocardial development and participates in the myocardial response to injury.
• Experimental animal models designed to identify and study the biological function of c-Kit-expressing cells produce varying and discrepant results likely in part because of variations in promoter and reporter design.
What New Information Does This Article Contribute?
• c-Kit expression increases in mouse and human cardiac progenitor cells in response to cellular stress.
• c-Kit is expressed in adult cardiac myocytes, and its abundance increases after cellular stress.
• c-Kit signaling promotes proliferation and survival in mouse and human cardiac progenitor cells.
• The novel, transgenic, inducible c-Kit reporter mouse model characterized in this study reveals previously unrecognized heterogeneous, dynamic c-Kit expression and biology in the postnatal myocardium.
The biological role of cardiac c-Kit has been largely overlooked in the cardiovascular research community because of overemphasis on the use of c-Kit as a marker for stem cells. The protective and proproliferative effects of c-Kit signaling in cardiac cells are central to their regenerative potential and their role in cardiac formation and repair. Heterogeneity of the cardiac c-Kit+ cell population including c-Kit activity in cardiac myocytes, confirmed with our novel transgenic reporter mouse, reconcile and extend prior divergent reports and point toward new horizons for c-kit biology in the myocardium. The biological role(s) for cardiac progenitor cells, including those expressing c-kit, in maintaining cardiac homeostasis and promoting repair is clearly more nuanced and complex than previously represented in the evolving field of myocardial regeneration.
hemizygous knock-in mice allows for covert existence of an invisible c-Kit+ subpopulation in the myocardium comprising 25% to 30% of all c-Kit+ expressing cells 9 that cannot be followed. Consequently, c-Kit knock-in mice may harbor c-Kit-dependent biological defects, impaired reporter sensitivity, and attendant uncertainty of the functional impact resulting from c-Kit allele hemizygosity that could affect proliferation and survival in culture.
An alternative approach to c-Kit+ tracking by knock-in techniques and associated allele inactivation is the use of transgenesis to introduce a cloned construct carrying a cKit promoter fragment driving expression of a long-lived reporter protein. The cloned c-Kit promoter used as a driver for reporter gene expression has been extensively characterized both in vitro and in vivo 3, 21, 22 but has never been adopted to serve for inducible tracing of cell fate in the myocardial context. Transgenesis minimizes allele inactivation and potential deleterious consequences of impaired c-Kit activity that could influence interpretation of c-Kit expression and relevance in myocardial biology. For the current study, we use a doxycycline-inducible transgenic mouse model to tag c-Kit+ cells with a long-lived, tetracycline-responsive H2BEGFP (CKH2B) reporter. 23 Endogenous c-Kit remains unperturbed, and ≈80% of nonmyocyte cardiac c-Kit+ cells express H2BEGFP reporter, similar to c-Kit coincidence with EGFP (enhanced green fluorescent protein) in a c-Kit/ mER-Cre-mEr knock-in reporter model (CKmCm). A heterogeneous CKH2B cell population is revealed after induction with doxycycline, including tagging of select adult cardiomyocytes (ACM) in vivo, a finding consistent with expression of c-Kit mRNA and protein in isolated ACMs. Increased expression of CKH2B in cultured ACM in response to stress is consistent with a role for c-Kit expression in cardiomyocyte survival, a finding recapitulated by acute pathological injury in vivo. Similarly, c-Kit activation in cultured mouse CPCs (mCPCs) and human CPCs (hCPCs) enhances proliferation and survival, in line with previous reports establishing the role of c-Kit signaling in human cardiac stem cells. 19 Collectively, data presented here support validity of the c-Kit reporter model, pointing to heterogeneous and dynamic c-Kit expression in the postnatal myocardium that facilitates reconciliation of seemingly disparate observations from published literature and resolves multiple aspects of the controversial role for c-Kit in cardiac biology.
Methods
The authors declare that all supporting data are available within the article [and its online supplementary files].
Mice
c-Kit/rtTA (reverse tetracycline-controlled transactivator) transgenic mice expressing the rtTA transactivator under control of the c-Kit promoter clone 2 21 were generated using standard genomics techniques and stabilized by breeding several generations into the FVB/N background. The CKH2B line was created by crossing cKit/rtTA mice with tet-responsive element (TRE)-H2BEGFP mice purchased from Jaxmice (stock number: 005104/pTRE-H2BEGFP). Copy number of the c-KitrtTA transgene per cell was determined by a quantitative polymerase chain reaction (qPCR) as described 24 with the following modifications. c-KitrtTA plasmid injected for transgenesis was used to establish the standard curve ranging in concentration from 5 fg to 5 ng of plasmid template per reaction. Genomic DNA was extracted from livers of mice hemizygous for the c-KitrtTA transgene or from non-rtTA controls. The qPCR mix consisted of iQSYBR Green master mix, 50-ng genomic DNA, and primers specific for rtTA and 18S, and was performed using a CFX Connect Bio-Rad cycler for 40 two-step cycles at 95 and 60°C. A logarithmic standard curve was generated and copy number calculated per cell based on the assumption that each cell contains 6-pg genomic DNA or that 1-ng DNA is the equivalent of 167 diploid cells. Genotyping of mice to detect rtTA and EGFP transgenic sequences in genomic tail DNA was performed by standard PCR using target-specific primers. All primers for measuring copy number and genotyping are listed in Online Table I . c-Kit-MerCreMer/R26-NG (CKmCm) mice were created by crossing the Kit-MerCreMer driver line 9 to the FVB.Cg-Gt(ROSA)26Sortm1(CAG-lacZ,EGFP)Glh/J from Jaxmice (stock number 012429) 25 .
Animal Procedures
All procedures and experiments involving mice were approved by the SDSU Institutional Animal Care and Use Committee. Acute diffuse injury was achieved by administering a single subcutaneous injection of 150 mg/kg isoproterenol. H2BEGFP reporter expression was induced in vivo with 0.2 mg/mL doxycycline in the drinking water for up to 4 days. CKmCm, 3-month-old, male mice were fed normal chow or chow containing tamoxifen citrate for 4 weeks to induce EGFP reporter expression, after which hearts were retroperfused and fixed in formalin for paraffin processing.
For flow cytometry analysis of heart and bone marrow, CKmCm mice were fed tamoxifen chow for 4 weeks followed by 4 weeks chow with no tamoxifen.
Cell Isolation and Expansion
Murine CPCs and ACMs were simultaneously isolated from transgenic hearts using a modified isolation protocol. 26 Briefly, hearts were cannulated via the aortic arch and perfused for 15 minutes at 37°C in digestion buffer containing Liberase, then physically dissociated in digestion buffer at 37°C. Myocytes were filtered through a 100-µm nylon mesh and separated from nonmyocyte cardiac cells (NMC) by gravity sedimentation. Fractions of myocytes and NMC were collected from 3 subsequent steps of digestion, sedimentation, and filtration. Myocytes were plated on laminin-coated slides or dishes. The nonmyocyte fraction was either analyzed for EGFP and c-Kit expression by flow cytometry or filtered through a 40-µm nylon mesh and subjected to magnetic cell sorting to deplete the CD45+ population and enrich for cKit-expressing cells using the Miltenyi magnetic sorting system (catalog number 130-090-312; mouse CD45 microbeads catalog number 130-052-301; and mouse CD117 microbeads catalog number 130-091-224). CPCs were expanded in a humidified incubator at 37°C, 5% CO 2 in growth media consisting of 1:1 DMEM/Ham F12 (DMEM/F12; Life Technologies) and Neurobasal Media (Life Technologies) containing 10% ES-FBS (embryonic stem cellqualified fetal bovine serum; Life Technologies), LIF (leukemia inhibitory factor; 10 ng/mL; Millipore), bFGF (basic fibroblast growth factor; 10 ng/mL; Peprotech), EGF (epidermal growth factor; 20 ng/mL; Peprotech), 1× insulin-transferrin-selenium (ITS 500×; Lonza) 1% penicillin/streptomycin/2 mmol/L glutamine (100× PSG; Life Technologies), supplemented with B27 and N2 (Life Technologies). hCPCs were isolated from human LVAD (left ventricular assist device) discard tissue and expanded as previously described. 27 Briefly, tissue was digested with collagenase, nonmyocyte cells were separated by low-speed centrifugation (350g for 5 minutes), sequentially filtered through 100-and 40-μm filters, and cultured for 1 day at 37°C, 5% CO 2 in hCPC growth media (HAM's F12 supplemented with 10% ES-FBS, 5 mU/mL human EPO [erythropoietin], 10 ng/mL human bFGF, 0.2 mmol/L glutathione, 1× penicillin/streptomyocin/glutamine), after which the c-Kit+ population was selected by incubating with magnetic bead conjugated c-Kit antibodies (Miltenyi Biotec catalog number 130-091-332) and MAC (magnetic-activated cell sorting) sorting.
Magnetically separated cells were expanded for at least 5 passages in hCPC growth media before use in experiments. Adult hCPCs were used at passages 6 to 10 in all experiments.
Statistics
Two-tailed t tests were used to compare to 2 groups for all analyses other than the linear mixed model for Figure 5 as described below. P<0.05 is considered statistically significant. . c-Kit protein and RNA were quantified in mouse CPCs (mCPCs) and human CPCs (hCPCs) cultured in full or low serum media. c-Kit protein levels increase 2-fold in mCPCs cultured for 24 h in low serum vs full growth media as measured by immunoblotting (A). c-Kit RNA levels in mCPCs exposed to low serum increase 3-fold as measured by quantitative polymerase chain reaction (B). hCPC culture for 5 days in low serum exhibit an initial decrease in c-Kit protein levels, which return to full serum levels by 5 d (C), whereas c-Kit mRNA increases steadily over time (D). Decreased proliferation in mCPCs and hCPCs cultured in low serum is partially rescued by SCF treatment as indicated by BrdU (bromodeoxyuridine) incorporation (green=BrdU, E [mCPC] and F [hCPC]) and daily cell counts (G and H). Doubling time of CPCs calculated from growth rates increases after serum depletion but is restored with addition of stem cell factor (SCF; G and H). Table III provides values for efficiency of coexpression assessed with c-Kit+/EGFP+ coincidence in 3 experiments using CKH2B and CKmCm mouse heart samples. Figure 1 Continued. Viability is higher, whereas apoptosis and necrosis are lower in SCF-treated CPCs as measured by AnnexinV/PI flow cytometry analysis (I and J). Specific activation of c-Kit in mCPCs and hCPCs is confirmed by increased phosphorylation of c-Kit, ERK (extracellular signal-regulated kinase), and AKT after SCF treatment (K and L). n=3 for all experiments. P<0.05 denotes statistical significance. Statistical significance between 2 groups was determined by unpaired t test for all data except (J), which was analyzed by paired t test. *P<0.05, **P<0.01, and ***P<0.001.
Results c-Kit Signaling Promotes Proliferation and Survival in CPCs
c-Kit signaling stimulates proliferation and enhances survival in multiple cell types, [28] [29] [30] including human cardiac stem cells. 19 Mouse and human CPCs were assayed for c-Kit expression, proliferation, and cell death in response to low serum culture conditions. Serum starvation for 24 hours induces a significant 73% increase in c-Kit protein and 3-fold higher levels of c-Kit mRNA in mCPC ( Figure 1A and 1B), whereas c-Kit protein levels in hCPC initially decrease by 60% at 24 hours and return to full serum levels after 5 days of starvation, as measured in 3 distinct lines ( Figure 1C ). Interestingly, c-Kit mRNA levels increase by 63% in hCPCs after 24 hours and rise to >3-fold by 5 days in low serum ( Figure 1D ). Treatment of serum-starved mCPC and hCPC with c-Kit ligand SCF significantly enhances BrdU (bromodeoxyuridine) incorporation by 84% and 37%, respectively ( Figure 1E and 1F). Similarly, SCF treatment increases cell growth rate and shortens doubling time in serum-starved cells ( Figure 1G and 1H), confirming the proproliferative activity of c-Kit signaling in CPCs. Viability in serum-starved mCPCs is significantly higher, and cell death significantly blunted in cells treated with SCF, as measured by a 14% increase in cell survival and 63% decrease in both apoptosis and necrosis using flow cytometry, indicative of protective c-Kit signaling in these cells. Likewise, SCF-treated hCPC exhibit a significant 13% increase in viability, and 29% and 28% downward trends in apoptosis and necrosis, respectively ( Figure 1I and 1J). Activation of c-Kit by SCF is verified in mouse and human CPCs as evidenced by Figure IF) ; nevertheless, c-Kit is detected in the majority of fixed mCPCs assessed by flow cytometry (Online Figure  IF) and immunofluorescence (Online Figure X) . Collectively, these data demonstrate that the c-Kit pathway is active in mouse and human CPCs and that c-Kit signaling promotes CPC proliferation and survival in low serum conditions.
Cardiac Myocytes Express Active c-Kit and Upregulate c-Kit in Response to Stress In Vitro
Prior studies have reported increased cardiac c-Kit expression in myocytes after myocardial injury. 4 Isolated ACM immunolabeled for c-Kit confirms myocyte-specific c-Kit protein expression (Figure 2A ; Online Figure IIB and IIC). c-Kit was detected in most ACM, whether fixed immediately after isolation or plated for 2 hours and then fixed. Using either method, c-Kit staining was found in the majority of ACM (79.25%, or 42 out of 53 immediately fixed ACM). Upregulation of phospho-ERK and phoshpo-AKT in ACM treated with SCF verifies activation of c-Kit activity in these cells ( Figure 2B ; Online Figure IIA) . Finally, c-Kit protein and mRNA levels are elevated 2-fold in isoproterenol-treated ACMs ( Figure 2C ). Taken together, these results indicate that mouse ACMs express c-Kit mRNA and protein, exhibit c-Kit pathway activation by SCF, and upregulate c-Kit expression in response to cellular stress in vitro.
H2BEGFP Reporter Is Expressed in Transgenic Cardiac and Noncardiac c-Kit+ Cells In Vivo
An inducible transgenic c-Kit reporter mouse was created to further probe cardiac c-Kit biology in vivo. The rtTA transcription factor was cloned downstream of a previously characterized 14 kb fragment of the mouse c-Kit promoter 3, 21 to generate the c-KitrtTA mouse line (Online Figure III). c-KitrtTA mice were crossed with mice harboring the tetracycline-responsive H2BEGFP reporter construct (TRE-H2BJ/eGFP; Online Figure IIIB ) 23 to create a double transgenic line in which doxycycline treatment induces H2BEGFP expression in cells harboring an active c-KitrtTA construct (CKH2B; Online Figure IIIC and IIID). c-KitrtTA transgene copy number was calculated to be ≈4 copies per diploid genome in hemizygous animals, as measured by qPCR of genomic DNA using a previously described method (Online Figure IV) . 24 Transgene expression was validated in CKH2B mice treated with doxycycline ( Figure 3) . Cardiac c-Kit+ cells from doxycycline-treated CKH2B mice express the H2BEGFP reporter in the nucleus, as illustrated by immunolabeling of paraffin sections ( Figure 3A ) and freshly isolated, unfixed NMC immunolabeled for c-Kit and analyzed by flow cytometry (Figure 3B and 3D Table III) , consistent with flow cytometry data for CKH2B+Doxy nonmyocyte ( Figure 3F and 3G) or CKmCm+Tx bone marrow cells. 9 Moreover, density of c-Kit+ cells per unit area is significantly higher in CKH2B versus CKmCm heart tissue sections ( Figure 4B ). This rigorous, blinded analysis reveals that the transgenic (CKH2B) reporter mice possess 2.2-fold higher cardiac c-Kit+ cell population density and a trend toward higher EGFP tagging of c-Kit+ cells relative to the knockin (CKmCm) mice. However, neither model successfully tags all c-Kit+ cells with EGFP, demonstrating a similarity consistent with heterogeneity of the endogenous cardiac cKit cell population. Additionally, NMC were isolated from tamoxifen-treated CKmCm mice and analyzed for c-Kit and EGFP+ by flow cytometry. Consistent with findings in paraffin sections, the percentage of c-Kit+ NMC is approximately half of the level observed in CKH2B NMC (5.8±1.1% SD versus 13.8±3.8% SD, respectively; Figure 4C ). Interestingly, the EGFP+ population was substantially lower in CKmCm BM and nonmyocyte than in CKH2B (0.04±0.02% SD versus 4.7±2.7% SD nonmyocyte, 2.9% versus 20.4% BM in CKmCM and CKH2B, respectively; Online Figure VIC) . Discrepancies in reporter expression may be due in part to differences in mouse strain and reporter induction protocol; however, the lower proportion of EGFP+ cells in CKmCm is also consistent with the c-Kit haploinsufficiency.
H2BEGFP Reporter Is Expressed in CKH2B Adult Cardiac Myocytes
c-Kit expression has been reported in neonatal mouse cardiomyocytes and genetically tagged mouse ACMs 4, 9, 31, 32 and measured in ACM (Figure 2) . Therefore, expression of H2BEGFP reporter in myocytes was tested by immunolabeling for EGFP and cardiac myosin light chain in heart tissue from CKH2B mice treated with doxycycline for 1 or 4 days ( Figure 5A and 5B). Quantification of H2BEGFP signal in all nuclei and in myocyte nuclei reveals that ≈1.8% of all cardiac nuclei express H2BEGFP after 1 day of induction, increasing to 6% by 4 days of treatment ( Figure 5C ). Cardiac myocyte nuclei positive for H2BEGFP comprise <0.1% of all nuclei at 1 day, and 0.5% of all nuclei by 4 days of induction ( Figure 5D ), whereas the proportion of cardiac myocytes expressing H2BEGFP reporter increases from 0.1% to 2.5% between 1 and 4 days, respectively ( Figure 5E ). ACMs isolated from doxycycline-treated CKH2B hearts exhibit discreet nuclear H2BEGFP fluorescent signal in 9.4% of total myocytes (Online Figure VIIA; Figure 7F ). Likewise, naive CKH2B ACM treated with doxycycline postisolation express H2BEGFP (Online Figure VIIB) . Taken together, these data confirm c-Kit expression in mouse ACM (Figure 2A ) and demonstrate sensitive detection of c-Kit expression in the cardiomyocyte population as revealed by cumulative H2BEGFP expression over time with doxycycline induction. Additionally, paraffin sections of tamoxifen-induced CKmCm were immunolabeled for EGFP and a cardiomyocyte marker to identify EGFP+ myocytes in the knock-in hearts. Between 1 and 5 EGFP+ myocytes were detected per heart section in 3 individual CKmCm hearts (Online Figure  VID) . Collectively, these data provide further evidence that c-Kit is expressed in adult cardiac myocytes.
H2BEGFP Is Expressed in CKH2B Bone Marrow Stem Cells In Vitro
Bone marrow is an established source of c-Kit-expressing stem cells. c-Kit+ bone marrow stem cells (BMSC) were isolated as previously described 33 from CKH2B mice, expanded, and treated with doxycycline in vitro to assess transgene expression in a c-Kit-enriched stem cell system. As shown by live fluorescence imaging, untreated BMSC express no fluorescent signal (Online Figure IXA) , whereas cells exposed to doxycycline exhibit induction of robust, chromatin-associated H2BEGFP fluorescence consistent with expected histone distribution (Online Figure IXB and IXC) . Flow cytometry and confocal microscopy analyses of fixed, immunolabeled BMSCs further confirm low baseline reporter signal in untreated BMSCs (Online Figure IXD and IXH) and robust induction of H2BEGFP in doxycycline-treated CKH2B (Online Figure IXE , IXF, and IXI) but not in single transgenic c-KitrtTA BMSC (Online Figure IXG) . Coexpression of c-Kit with the H2BEGFP signal is detected in ≈60% of the total c-Kit+ BMSC population, as measured by flow cytometry (Online Figure IXF) . BMSCs labeled for flow cytometry and imaged by confocal microscopy exhibit membrane c-Kit and nuclear H2BEGFP signals (Online Figure IXI) . Cumulatively, these data demonstrate robust and appropriate induction of the H2BEGFP reporter in a cultured stem cell population enriched for c-Kit expression, consistent with previous publications characterizing the CKH2B promoter construct. 
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CKH2B CPCs Express c-Kit and H2BEGFP Reporter In Vitro
Cardiac c-Kit Expression Increases After Diffuse Injury In Vivo
Diffuse injury induces transient proliferation of CPCs in vivo. 8 Mice received a single injection of 150 mg/kg isoproterenol subcutaneously, and hearts were analyzed by immunostaining or flow cytometry 3 days later. Consistent with previous reports, the c-Kit+ nonmyocyte population increased (12.6%-20.1% in control versus injured hearts) as measured by flow cytometry (Online Figure XIC) . CKH2B mice received a single injection of isoproterenol and treated with doxycycline for 3 days, and c-Kit colocalization with H2BEGFP was measured by immunolabeling in paraffin sections or flow cytometry on isolated nonmyocyte to assess the impact of diffuse injury on transgene expression. The H2BEGFP+ nonmyocyte population increased by 63% (4.9%-8.0% of ungated nonmyocyte), whereas the proportion of c-Kit+ H2BEGFP NMC declined from 29.5% to 20.7% in uninjured versus injured hearts, respectively (Online Figure XIC) . The proportion of mesenchymal/stromal cells, as marked by CD105, CD90.1, and PDGFRα, all increased within the total nonmyocyte and EGFP+ nonmyocyte populations (Online Figure XID and  XIE) , supported by clear colocalization of vimentin with EGFP+ in damaged regions of cardiac CKH2B tissue sections (Online Figure XIA) . The percentage of c-Kit+ cells labeled for H2BEGFP in injured heart was comparable to uninjured controls (75.7% vs 71.9%, respectively; Figure 7A , 7B, and 7D). Cells coexpressing CD45 and EGFP were detected in injured areas of cardiac tissue sections (Online Figure  XIB) , while flow cytometry analysis indicates a decrease in the CD45+/H2BEGFP+ nonmyocyte population from 27% to 11% in uninjured versus injured hearts. The total number of c-Kit cells per area was 3.1 versus 1.1 per mm 2 in injured versus uninjured heart sections ( Figure 7C ), consistent with flow cytometry data and previous reports of elevated c-Kit cell numbers in isoproterenol-treated hearts 3 days after injury. 8 Prior studies have reported evidence for c-Kit expression in myocytes.
4,9,10,31,32 Therefore, expression of H2BEGFP was assessed in cardiac myocytes isolated from hearts of CKH2B mice receiving a single injection of isoproterenol and treated with doxycycline for 3 days. H2BEGFP signal increased overall in isoproterenol-treated hearts as measured by immunolabeling for EGFP and cardiac myosin light chain ( Figure 7E ). Total EGFP-positive nuclei rose from 6% in unchallenged hearts to 17% after injury, the EGFP-positive myocytes increased from 0.5% to 3% of total nuclei, and the proportion of EGFP-labeled myocytes was 13% of the myocyte population versus 3% in control hearts ( Figures 3E and 7F) , consistent with the upregulation of c-Kit in ACMs treated with isoproterenol in vitro ( Figure 2C) . Furthermore, the percentage of H2BEGFP+ ACM isolated from isoproterenol-injured CKH2B hearts was >3-fold higher than those from uninjured controls (33.3% versus 9.4%, respectively; Figure 7F and 7G), and protein levels of c-Kit and H2BEGFP were also elevated in ACM from isoproterenol-treated animals ( Figure 7H ). These data strongly support evidence for c-Kit expression in adult cardiac myocytes in vivo and in vitro and emphasize a previously underappreciated and potentially important role for c-Kit signaling in the cardiomyocyte response to stress.
Discussion
Over a decade of cumulative research supports the important biological role of c-Kit+ cells in cardiac development, homeostasis, and repair, 2,8,22,34,35 although recent studies using genetically modified knock-in mice have challenged certain aspects of c-Kit-mediated contribution to myocardial regeneration. 9, 36 Knock-in mouse models thus far commonly focus on the property of c-Kit as a canonical stem cell marker originally identified in the hematopoietic context but devote relatively little attention to the critical biological role of cKit-dependent signal transduction. Regarding c-Kit as a perfunctory marker of stem cells overlooks substantial evidence that c-Kit signaling is an important determinant of myocardial biology and the molecular response to pathological injury. 19, 37 Findings presented here report biologically relevant c-Kit function in CPCs and myocytes, with important implications for the role of c-Kit expression and signaling in the cardiac injury response.
c-Kit is a type III receptor tyrosine kinase comprised an extracellular ligand-binding domain, transmembrane region, and intracellular kinase signaling domain. Binding of c-Kit ligand SCF initiates receptor dimerization, autophosphorylation, and activation of intracellular signaling cascades such as PI3K (phosphatidylinositide 3-kinase)/AKT and Ras/MAPK (mitogen-activated protein kinase)/ERK. AKT and ERK signaling downstream of c-Kit confers powerful protective and proliferative effects in the heart and other tissues. 14, 15, 37, 38 In the myocardial context, SCF-mediated activation of cKit or overexpression of constitutively active c-Kit protects against cardiomyopathic challenge, 38 whereas defective c-Kit signaling leads to compromised cardiac function in response to age and stress. [39] [40] [41] Consistent with published literature, findings obtained using isolated ACM demonstrate that c-Kit protein is functionally present and responsive to SCF exposure (Figure 2A through 2C ; Online Figure II) . Furthermore, c-Kit expression increases in ACMs after adrenergic stress ( Figure 2C) , potentially contributing to a protection of the myocardium from pathological injury.
Concluding that c-Kit expression in cardiomyocytes is a normal biological process is reinforced by studying genetically engineered mouse models using 3 distinct c-Kit promoter systems including transgenic c-Kit-BAC (bacterial artificial chromosome) reporter 4 and c-Kit locus knock-in systems. 9, 18, 31, 42 Instant on c-Kit expression tagging in a c-Kit knock-in model demonstrated reporter expression in adult cardiac myocytes, 31 consistent with H2BEGFP tagging of myocytes in CKH2B hearts after 4 days of doxycycline treatment (Figure 4 ). In the wake of pathological damage to the myocardium, EGFP signal in c-Kit-BAC border zone myocytes after cryoinjury indicates activation of c-Kit expression in stressed cardiomyocytes 4 is consistent with higher incidence of H2BEGFP in ACMs isolated from isoproterenol-injured CKH2B hearts ( Figure 7E through 7H) and elevated c-Kit protein levels in isoproterenol-treated ACMs ( Figure 2C ). Sample preparation and detection method influence outcomes of quantitative assessments, as exemplified by comparing findings using immunolabeled paraffin sections versus freshly isolated ACM. The percentage of EGFP+ cardiomyocytes in paraffin sections (2.5%) represents an in situ view of the heart in which tissue content and context are preserved, yet epitope availability to antibodies may be diminished because of tissue processing. In comparison, the percentage of freshly isolated EGFP+ ACM from CKH2B hearts (9%) represents the end product of a multistep preparation that selects for cardiomyocytes that survive myocardial digestion and enrichment procedures. Furthermore, c-Kit protein is not detected in all EGFP+ cells in CKH2B cardiac cells because levels of c-Kit protein versus mRNA expression do not necessarily directly correlate (Online Figure VG) . Another contributing factor in this observed discrepancy is sensitivity of c-Kit detection. For example, directly conjugated c-Kit antibody is used for detection of c-Kit in unfixed EGFP+ cells ( Figure 3D and 3E) . However, fixation and permeabilization of cells increases the proportion of c-Kit+ cells in the population because some c-Kit protein is intracellular. 16 Furthermore, applying unconjugated c-Kit primary antibody followed by a fluorescently tagged secondary yields higher sensitivity for detection of c-Kit protein because of increased fluorophore labeling. These methodological considerations can also contribute to variation in correlation between c-kit protein and EGFP reporter detection. Thus, derivation of quantitative findings using multiple approaches as performed in this study marginalizes bias in experimental design and helps to reconcile discrepant observations from prior publications. Consistent documentation of c-Kit in ACM supports a regulatory role in biological processes and validates appearance of the CKH2B reporter in the present study as a reasonable and relevant indicator for c-Kit expression in ACMs. Differential induction of the 2 mouse models is an important discussion point. Although tagging efficiency of c-Kit+ cells is comparable in the 2 mouse models, the underlying genetics and induction protocols are dramatically different. To generate the EGFP+ tag in c-Kit+ cells in the knock-in model, CKmCm mice ingest tamoxifen in their feed for 4 weeks to affect permanent Cre-mediated recombination, whereas CKH2B animals imbibe doxycycline in their water for 4 days to drive expression of the H2BEGFP+ reporter. In the first system, EGFP+ cannot accumulate after recombination, unlike the tet-inducible system directly driving expression of H2BEGFP. These differences in reporter expression mechanisms influence reporter induction dynamics between the 2 models, in addition to the distinct c-Kit promoters used for tissue-specific expression.
Induction and activation of c-Kit in CPCs echo findings in ACMs. c-Kit signaling confers protective, proliferative, and promigratory effects through induction of ERK and AKT in adult human and rat CPCs. 19, 41 Likewise, the SCF/c-Kit pathway promotes proliferation in CPCs stimulated by coculture with MSCs. 43 Consistently, c-Kit levels increase in mouse CPCs after cellular stress ( Figure 1A and 1B) . Interestingly, in human CPCs, c-Kit protein levels decrease and recover after 5 days in low serum, whereas c-Kit mRNA increases steadily from 1 to 5 days in low serum ( Figure 1C and 1D) . Furthermore, SCF-mediated activation of c-Kit promotes CPC proliferation and blunts cell death in both mCPC and hCPC ( Figure 1E through 1J) , demonstrating the functional biological role of c-Kit in CPCs. Again, as is true for ACM, genetically engineered fluorescent tag reporter models contribute support for relevance of c-Kit cell biology through visualization and tracking of cardiac c-Kit+ cells in vivo and in vitro.
3,4,9,10,31 The tetracycline-responsive H2BEGFP reporter was deliberately chosen for our study based on literature precedents as a long-lived, easily identifiable chromatinassociated fluorescent tag originally designed for stem celltracking studies. 23, 44 Combined with the transgenic c-KitrtTA promoter, the resultant CKH2B reporter system presented in this report provides a sensitive, inducible readout for c-Kit expression without impacting endogenous c-Kit function consequential to targeted knock-in approaches that take advantage of the endogenous promoter but, by inherent necessity of experimental design, inactivate normal transcriptional activity of the c-Kit locus.
Another critical aspect of further validating the H2BEGFP model as a tool for investigating cardiac c-Kit cell biology is in consistency with numerous reports detailing phenotypic and morphological properties of CPCs. 2, 3, 8, 22, 45, 46 H2BEGFP-tagged cells in transgenic hearts exhibit typical morphology of small, round c-Kit+ cells embedded in the myocardium ( Figure 3A) . Induction of H2BEGFP expression revealed by confocal analyses of paraffin sections and flow cytometry of freshly isolated nonmyocyte cardiac cells ( Figure 3B through 3E ) matches reports with other c-Kit reporter models. 9 Likewise, CPCs isolated and expanded from CKH2B hearts exhibit classic CPC spindle morphology, express c-Kit, and upregulate H2BEGFP after doxycycline treatment ( Figure 6 ; Online Movie I; Online Figure X ). These fundamental characterizations together with concurrence between our findings and prior publications 2, 46 reinforce the fidelity and authenticity of c-Kit properties as revealed in the H2BEGFP transgenic model. Cardiac c-Kit cell expansion occurs in diffuse injury models in vivo. 47, 48 Analysis of c-Kit+ cells in isoproterenol-injured CKH2B hearts revealed sites of c-Kit+/H2BEGFP+ clusters and, interestingly, significantly more H2BEGFP+ cardiomyocytes in vivo and in vitro (Figure 7) , consistent with elevated c-Kit expression in isoproterenol-treated ACMs ( Figure 2C ) and reminiscent of EGFP-positive myocytes in border zone myocytes of c-Kit-BAC-EGFP hearts. 4 Upregulation of c-Kit in CKH2B myocytes in response to stress further substantiates a previously unrecognized or underappreciated biologically relevant role for c-Kit signaling in cardiac myocytes.
c-Kit+ cells constitute a highly heterogeneous population with broad distribution and diverse function throughout the body postulated to possess a range of phenotypic and biological properties. 35 The cardiac c-Kit+ cell subpopulation likewise comprises a diverse cell pool purported to participate in both direct contribution to tissue formation by lineage commitment and indirect paracrine-mediated signaling. 35, [49] [50] [51] Tagging efficiency of such a heterogenous cell population will inevitably vary with promoter expression levels, whether endogenous or transgenic, and may be affected by the hemizygous state of current c-Kit knock-in reporter models. Interestingly, up to 35% of cardiac c-Kit+ cells do not express a genetic reporter tag in either system, as measured by flow cytometry and immunolabeing of paraffin sections (Figures 3 and 4) , 9 further highlighting the complexity of c-Kit expression dynamics. Although ≈70% of H2BEGFP+ NMC are negative for c-Kit protein by flow cytometry (Online Figure VE and VF), these EGFP+/c-Kit NMC possess c-Kit mRNA by real-time qPCR (Online Figure VG) consistent with CKH2B transgenic promoter activity reflecting endogenous c-Kit mRNA expression. EGFP+ NMC diversity is readily apparent from immunoprofiling that shows heterogeneity of immune cell, interstitial cell, and mesenchymal/stromal markers including FceR1, F4/80, CD206, vimentin, CD105, CD90.1, and PDGFRα (Online Figures ID and VE) . Such heterogeneity warrants cautious interpretation of c-Kit+ cell biology consistent with the existence of multiple distinct subpopulations possessing nuanced differential characteristics that are lost on imposition of assessments focused on average measurements.
Genetic knock-in models that disrupt the c-Kit locus by necessity confer a hemizygous genotype for c-Kit. Given the proliferative and protective roles of c-Kit signaling in CPCs and evidence for survival signaling in ACMs, it is important to consider the potential impact of the hemizygous c-Kit phenotype on cardiac function and repair. Indeed, frequency of c-Kit cells decreased ≈50% in myocardial tissue sections from knock-in versus transgenic samples ( Figure 4B ), perhaps a consequence of differences in c-Kit gene dosage (hemizygosity in the CKmCm knock-in mice), strain (FVB for CKH2B and C57Bl/6 for CKmCm), or reporter system (direct TRE-mediated induction in CKH2B versus Cre-mediated recombination in CKmCm). One explanation for the difference in cell labeling between the knock-in and the transgenic models could be a feed-forward mechanism whereby disruption of one copy of c-Kit expression in the knock-in model leads to reduced c-Kit levels in all cells that express c-Kit. Impairment of c-Kit function leads to unequivocal phenotypic consequences in Wv (white spotting variant) c-Kit mutant mice that exhibit impaired cardiac recovery after infarction, diminished cardiac function with advanced age, and compromised c-Kit cell terminal differentiation into cardiomyocytes. 32, [39] [40] [41] Circumspection is reasonable when considering the myocardial response to injury in c-Kit hemizygous mice that could compromise reparative capacity of c-Kit+ cells in myocardial regeneration. Reporter models that do not disrupt the endogenous locus, such as the previously described c-Kit-BAC-EGFP transgenic 4 or the inducible CKH2B system described here, bypass interference with endogenous c-Kit expression and associated changes in cellular function. Given the preponderance of evidence as cited in preceding paragraphs to substantiate the biological role for c-Kit in the normal and injured myocardium, inescapable c-Kit allele inactivation should not be readily dismissed or deemed irrelevant from interpretation of results using genetically engineered knock-in models.
Together with the advantage of preserving normal endogenous c-Kit regulation, the CKH2B tagging system uses a transgenic c-Kit promoter to express rtTA transcription factor combined with a tet-responsive ubiquitous H2BEGFP reporter line. Doxycycline-mediated transgene induction can be performed at any stage of development without the potential adverse side effects of tamoxifen treatment in pregnant dams. [52] [53] [54] [55] [56] [57] Protein stability of H2BEGFP, with a reported halflife of several months in vivo, 44, 58 provides long-term tagging of c-Kit+ cells in CKH2B mice, while allowing for reversibility in mitotically active systems. Permanent tagging of cKit cells allowing for long-term lineage tracing of cells has been initiated through combining the c-KitrtTA transgenic construct with a tetracycline-responsive Cre line 59 and the ROSA mT/mG reporter mouse. 60 Future studies using various cKitrtTA transgenic models will establish distribution of c-Kit+ cells in the heart and clarify participation of c-Kit+ cells in response to cardiac injury.
In summary, the biological role of cardiac c-Kit is an important one that may be underappreciated because of an overemphasis on the use of c-Kit as a marker of stem cells. Proproliferative and protective effects of c-Kit signaling in cardiac cells are central to their regenerative potential and should be considered when designing experimental models to assess their role in cardiac formation and repair. All genetic lineage-tracing models have inherent limitations. Knock-ins frequently disrupt expression of the gene of interest and impair normal biological regulation, whereas transgenic promoter constructs may lack regulatory elements of the endogenous gene. Multicomponent lineage-tracing models designed to mark cells temporally and spatially harbor inducible or regulatable elements or rely on enzymatic recombination for tagging, introducing further layers of complexity and inescapable variables in efficiency, specificity, or even toxicity. In the final analysis, all experimental models are tools, with even the most sophisticated promoter-driven reporter models unable to precisely capture post-transcriptional regulation of c-Kit expression. For example, recent studies reveal that c-Kit translation, but not transcription, is regulated by Pim1 kinase in the hematopoetic stem cell pool. 61 Similarly, retinoic acid controls c-Kit translation through PI3K/Akt/mTOR (mammalian target of rapamycin) during spermatogonial differentiation. 62, 63 Additionally, microRNA 221 downregulates c-Kit protein expression in melanoma, hyperglycemic HUVECs (human umbilical vein endothelial cells), and PDGF (platelet-derived growth factor receptor)-stimulated vascular smooth muscle cells. [64] [65] [66] [67] Multiple layers of c-Kit protein regulation dependent on posttranslational modification, ubiquitination, internalization, and degradation rate all contribute to dynamic c-Kit expression beyond the reach of any one reporter system to reflect endogenous c-Kit biology. Acknowledging that there is much still to learn and embracing variations in perspectives rooted in divergent experimental models will resolve discrepancies, unify the cardiovascular research community, and provide new avenues for exploration moving forward with a renewed respect for the complexity of myocardial c-Kit biology.
